- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Share Purchase Plan Raises Additional $0.55 Million
SensOre (ASX: S3N or the Company) aims to become the top performing global minerals targeting company through deployment of big data, artificial intelligence/machine learning technologies and geoscience expertise.
SHARE PURCHASE PLAN
SensOre is pleased to announce that in addition to the $1m placement announced on 11 May 2023, the Company has raised a further $548,500 in the Share Purchase Plan (SPP). SensOre will issue 2,194,000 shares and 1,097,000 options to SPP participants today and will dispatch holding statements on Wednesday 14 June 2023, in accordance with the SPP timeline.
Under the terms of the SPP offer, eligible shareholders were entitled to purchase up to $30,000 worth of shares at a subscription price of $0.25 per share, being the same price as the share placement which was also announced on 11 May 2023. The SPP offer also included the issue of one option for every two shares at an exercise price of $0.375 and expiry of 3 years. The SPP offer closed on 7 June 2023.
The Company is in advanced negotiations with those who have expressed interest in taking a placement of the shortfall from the SPP.
This announcement was approved and authorised for release by the CEO.
Click here for the full ASX Release
This article includes content from SensOre, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
Large-Scale Study Validates and Enhances BlinkLab’s Accuracy in Detecting Autism in Children
BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”), an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for autism and other neurological conditions, is excited to announce results from the latest study in autism confirming high-accuracy in detecting autism in children ahead of upcoming FDA registrational study.
Highlights
- Analysis of a study conducted in 441 children diagnosed for autism using current standard-of-care protocols showed that ‘BlinkLab Dx 1’ detected autism with an improved sensitivity of 91% and specificity of 85%.
- These results bolster confidence that BlinkLab Dx 1 will surpass the accuracy parameters required for regulatory approval in the upcoming FDA registration trial, scheduled to commence by the end of this calendar year.
- The study is an expansion of the prior study conducted by BlinkLab, in partnership with the Turning Pointe Autism Foundation in Illinois, Princeton University, and the National Center for the Disabled in Morocco. The study was undertaken using the latest version of our digital diagnostic platform, BlinkLab Dx 1, that includes a novel set of digital biomarkers and refined machine learning models.
- This new data highlights BlinkLab Dx 1 potential as a rapid accurate test in the growing autism diagnostics market which is expected to reach $5.41 billion by 2036. A recent industry report shows families face a three-year average wait for autism assessments and 21% of U.S. clinics are unable to accept new referrals due to high demand.
About the study
A multi-center, within-subject comparison study was conducted on 441 children aged 4 to 12 years, including 285 diagnosed with autism and 156 without. This sample size far exceeded the minimum required to power the study for statistical significance.
The study was conducted in accordance with all relevant guidelines and regulations and received approval from the institutional review boards of Princeton University (#13943) and the Faculté de Médecine et de Pharmacie de Marrakech in Morocco (#23/2022).
All neurobehavioral tests were administered using the BlinkLab smartphone-based platform. Assessments included general measures of spontaneous and stimulus-evoked postural, head, facial and vocal responses, as well as specific neurometric tests like prepulse inhibition and startle habituation. Each child completed two 15-minute sessions while watching an engaging video content, with auditory stimuli delivered via headphones. During each session, computer vision algorithms tracked and recorded the position of the children’s facial landmarks over time. Analysing spontaneous and stimulus-evoked responses along with prepulse inhibition and startle habituation performance, our machine learning algorithms achieved a sensitivity of 91% and specificity of 85%. This is a substantial improvement compared to the 85% and 84%, respectively, we reported in our previous study (ASX Announcement, 2 April 2024 – BlinkLab Prospectus 2024, page 47). The BlinkLab Dx 1 model also demonstrated robust and consistent performance across gender and age groups.
The results indicate that BlinkLab’s smartphone-based testing effectively identifies sensory sensitivities in children with autism, highlighting the potential of non-invasive digital biomarkers as a diagnostic aid for autism. Additionally, they reflect the benefits of BlinkLab's institutional collaborations over the past year, which have contributed to the ongoing training and refinement of our diagnostic models.
Significance of the project
Deficits in sensory processing represent a core feature of autism, which is typically assessed through subjective observations such as questionnaires or parent-child interviews and are susceptible to geographic and socio-economic biases. An objective approach to quantify sensory sensitivity is now possible through digital neurometric evaluations. The clinical application of these sensory assessments has been confined largely to laboratory settings that use fixed equipment to provide a stable test environment making it impossible to use at scale for clinical diagnosis. This study demonstrates that fast, scientifically validated smartphone- based tests can be widely deployed in clinical settings remotely and at scale. Unlike current time-intensive and costly multidisciplinary assessments which rely on specialist expertise and are often difficult to access, BlinkLab Dx1 test offers a more efficient and accessible alternative. Current wait times for a formal autism diagnosis using standard-of-care methods often extend up to three years, with individual assessments taking as long as eight hours to complete. Studies show that these delays impose a significant economic and healthcare burden on affected families and communities.
Click here for the full ASX Release
This article includes content from Blinklab Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
Spectur Awarded Long Term Contract with Transport for NSW
Solar security, sensing and visual AI solutions and platforms company Spectur Limited (ASX: SP3) (Spectur or the Company) is pleased to announce the signing of a three-year contract for $787,428 with Transport for NSW (Contract No: CW2592803), with optional extensions to nine (9) years (Total price – nine year term - $2,632,284).
Highlights
- Spectur entity 3 Crowns Technologies Pty Ltd has signed a contract with Transport for NSW for the provision of cameras and analytic services.
- The value of the three-year contract is a minimum $787,428 with an optional extension of a further three plus three years for a total of 9 years (Total price $2,362,284).
- Expansion to new sites included in this contract may increase the annual contract value between $50,000 and $200,000 subject to final scope confirmation, giving a potential contract value of almost $1.4M.
- Year to date sales exceeds all previous records with $4.18m sold (13 November YTD FY25), compared with $2.205m sold October YTD in FY24.
This contract includes the provision of the following services and products:
- Live webcam vision with night vision enabled cameras for 23 existing locations including all hardware supply, installation, maintenance, software and data provisions as a managed service
- Expansion of these 23 locations to new fixed locations. This is currently being scoped
- Provision of new mobile trailer systems. Quantity to be confirmed, with the potential to increase the base contract value of $ 787,427.
The contract follows on from an ongoing smaller contract with 100%-owned entity 3 Crowns Technologies Pty Ltd (3CT), which was extended by 6 months earlier in 2024 and will be replaced when this contract is implemented, anticipated to be in January 2025. There is an optional extension of an additional three plus three years, extending the potential duration of the contract to nine years. This contract will be executed through the 3CT entity.
Key material terms of the contract are included in Appendix A.
This contract win follows on from earlier substantial contract wins with other 3CT entities in Q1, in addition to general growth within the Spectur business. Total sales (including longer term contracts) to date this financial year (at 13 November 2024) are $4.18m, a 90% increase over FY24 October YTD results of $2.205m. Whilst many of these sales are longer term contracts and have not yet converted into revenue in FY25, they underpin long term, secured recurring revenues.
Executive commentary
Spectur Managing Director, Gerard Dyson, said:
“The portion of revenue that is coming from high gross margin recurring revenue continues to increase at Spectur, with current run rates in excess of 60% of total revenue. Many of the projects that form this growing base, including the recent win with Transport for NSW, arise through the growth of existing relationships and accounts. The Spectur ecosystem is becoming increasingly flexible and expandable, with an ever greater number of opportunities to add in third party AI, sensors, cameras, devices and other applications. It is becoming a core platform for many customers, and an increasing number of resellers.
“Spectur continues to win increasingly large projects as evidenced by the year-to-date sales. This funnel of revenue continues to grow and is the product of many years of cultivation that are bearing rewards now and into the future. Ongoing strong, high margin sales, combined with recent cost control activities in response to productivity improvement, underpins the ‘fitness’ of Spectur going forward. These long- term contracts ultimately reduce and then remove the requirements for hardware sales and service to cover costs, ushering in a new era of profitability and a platform for accelerating growth.”
Click here for the full ASX Release
This article includes content from Spectur Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
Tech 5: TSMC Gets US$6.6 Billion Biden Admin Grant, Bitcoin Price Hits New All-time High
Bitcoin reached new levels this week, then paused amid speculation about how high it could go.
Meanwhile, the Biden administration finalized a multibillion-dollar arrangement to bring advanced semiconductor manufacturing back to the US, and a nuclear energy firm backed by Sam Altman announced data center supply deals.
Stay informed on the latest developments in the tech world with the Investing News Network's round-up below.
1. Bitcoin price reaches new all-time high
Bitcoin's price has continued to soar in the wake of Donald Trump's US election victory, benefiting from bullish sentiment generated by anticipated crypto-friendly policies from the incoming government. The market capitalization of the crypto industry has surpassed US$3.14 trillion, higher than the GDP of Canada, Brazil and Italy.
After rallying last week, Bitcoin ended this week up 19 percent over seven days, boosted by the prospect of looser regulations and support for innovation under the Trump administration.
The world’s most popular cryptocurrency reached a new all-time high of US$80,000 on Sunday (November 10) and continued its upward trajectory, peaking for the week at US$92,435 on Wednesday (November 13).
Bitcoin performance, November 9 to 15, 2024.
Chart via CoinGecko.
Bitcoin exchange-traded funds (ETFs) experienced a surge in popularity as the price rose, with six consecutive days of inflows totaling US$4.71 billion as of Thursday (November 14). Analysts at Checkmate have identified demand for Bitcoin ETFs as the primary factor driving the surge in Bitcoin demand at the moment.
Additionally, Bitcoin futures open interest climbed to a notable US$55.07 billion.
However, Bitcoin struggled to maintain its hold above US$90,000, falling to the US$87,200 range after US Federal Reserve Chair Jerome Powell’s address in Dallas, Texas, on Thursday. Fresh data on Friday (November 15) morning showed US$400 million of net outflows from Bitcoin ETFs on Thursday, the third highest loss since the funds were listed.
A slight recovery followed later on Friday after news of a lawsuit against the US Securities and Exchange Commission (SEC) and Gary Gensler by 18 Republican attorneys general who are alleging overreach in crypto regulation.
Coinciding with this news, XRP, the native token of Ripple — a company currently involved in legal disputes with the SEC — saw a 17 percent increase in value. The lawsuit challenges the SEC's application of the Howey Test to classify cryptocurrencies as securities, arguing that the SEC's interpretation goes beyond the original scope of the Howey Test.
Plaintiffs, including the DeFi Education Fund, point to the SEC's case against Ripple Labs as a precedent. The judge in that case determined that XRP and similar cryptocurrencies are not inherently securities, even if initially offered as part of an investment contract. This ruling is now being referenced in other legal proceedings.
This ongoing legal challenge could further reshape the regulatory landscape for cryptocurrencies in the US in 2025.
As of 6:00 p.m. EST on Friday, Bitcoin was priced at US$91,246.49.
2. Biden admin finalizes CHIPS Act deal with TSMC
In a push to distribute CHIPS and Science Act funds, the Biden administration has finalized an incentive agreement with Taiwan Semiconductor Manufacturing (TSMC) (NYSE:TSM,TPE:2330).
Under the terms of the deal, the company will receive US$6.6 billion in federal grants to expand operations in the US. In a statement released on Friday (November 15), President Joe Biden said:
“The first of TSMC’s three facilities is on track to fully open early next year, which means that for the first time in decades, an American manufacturing plant will be producing the leading-edge chips used in our most advanced technologies — from our smartphones to autonomous vehicles, to the data centers powering artificial intelligence.”
According to administration officials, TSMC will receive a minimum of US$1 billion out of the total funding awarded this year, since it has already met certain performance targets.
The Biden administration has reportedly been amping up efforts to finalize deals with companies promised CHIPS Act funds, including large firms like Intel (NASDAQ:INTC) and Samsung Electronics (KRX:005930).
Earlier this month, a group of 18 companies sent a letter to the president, urging him to “work with members of your Cabinet and staff across your Administration to remove any roadblocks that may exist, ensuring that the funds highlighted as critical to the success of the objectives of these laws are delivered as promptly as possible.”
The act — which set aside US$39 billion in grants, US$75 billion in loans and loan guarantees and 25 percent tax credits to entice semiconductor companies to manufacture in the US — was criticized as “so bad” by President-elect Donald Trump during his campaign. There is widespread speculation that he may attempt to renegotiate the agreements.
3. Oklo signs letters of intent with data center providers
Oklo (NYSE:OKLO), a company that is developing advanced fission power plants, announced on Wednesday that it has received two letters of intent from major data center providers for up to 750 megawatts of power.
This development marks a major milestone for Oklo, which is backed by OpenAI’s Altman, and underscores the growing demand for sustainable energy solutions within the data center industry.
Oklo says its technology has the potential to revolutionize the way data centers are powered, providing a reliable and sustainable source of energy that can support ever-increasing demand for computing power.
The company focuses on developing micro reactors, which are smaller than traditional nuclear reactors. This makes them a more viable option as they are better suited for a variety of locations and applications.
While Oklo did not specify which data center operators it received the letters of intent from, the news demonstrates the commercial viability of its technology and the growing importance of nuclear power in the energy mix.
4. Applied Materials, Foxconn release quarterly results
Applied Materials (NASDAQ:AMAT), a leading provider of equipment and software used to manufacture semiconductors, unveiled results for its fourth fiscal quarter of 2024 on Thursday.
While the company's performance met market watchers' expectations, its revenue forecast of US$7.15 billion for its first fiscal quarter of 2025 fell short of estimates of US$7.25 billion.
The news resulted in a 9.81 percent decline in Applied Materials' share price for the week.
The company’s lower outlook suggests a slowdown in spending on semiconductor manufacturing equipment and indicates that chipmakers are potentially scaling back production expansion plans.
Meanwhile, Hon Hai Technology Group (Foxconn) (TPE:2354), a global electronics manufacturing giant best known for assembling iPhones, released its Q3 results ahead of expectations. The report highlights growing revenue from artificial intelligence (AI) servers, with orders for these servers making up over 40 percent of overall server revenue.
Foxconn projects that its AI server revenue will continue to grow, accounting for more than 50 percent of server revenue in 2025. The company relies on a steady supply of semiconductors to build these servers and its other products.
Foxconn's focus on server demand aligns with the increasing adoption of cloud computing and other data-intensive technologies, driven by the increasing use of cloud-based AI platforms.
5. OpenAI changes tactics as AI advances slow
According to a report published by the Information on Saturday (November 9), OpenAI's newer intelligence models are not exhibiting the same degree of progress as was observed between GPT-3 and GPT-4.
The news outlet states that testing of OpenAI's newest model, code named Orion, shows that the rate of improvement appears to be slowing down. During testing, Orion struggled to solve problems it hadn't been trained on.
The slowdown comes at a time when the availability of data to train AI models is declining. To address this issue, OpenAI has reportedly created a new team focused on improving its models’ capabilities — its strategies include using synthetic data produced by other AI models to train Orion and alter its post-training processes.
A Reuters article suggests that new training techniques will use more “human-like ways for algorithms to think." AI researchers told Reuters about a technique called test-time computing, which could enhance a model's ability to generate and assess multiple responses before selecting the optimal solution. This method could potentially provide models with increased processing power to tackle complex tasks such as solving math problems and coding.
Sources told Bloomberg that Anthropic and Alphabet (NASDAQ:GOOGL) are seeing similar slowdowns with their newer models, despite investing billions in developing sophisticated AI models and artificial general intelligence (AGI).
“The AGI bubble is bursting a little bit,” said Margaret Mitchell, chief ethics scientist at Hugging Face. “It’s become clear that different training approaches may be needed to make AI models work really well on a variety of tasks.”
Researchers developing new training techniques could shift demand away from chips used to train AI and toward “inference clouds,” described to Reuters by Sequoia Capital partner Sonya Huang as “distributed, cloud-based servers for inference." This is the process of an AI model applying its knowledge to new data before generating results.
Don't forget to follow us @INN_Technology for real-time news updates!
Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.
Syntheia: Game-changing Conversational AI Solutions for the Enterprise, SMB Markets
In an industry poised to transform customer engagement, Syntheia (CSE:SYAI) is an innovative conversational AI solution addressing the complex needs of modern communication. Designed to emulate human-like conversations, Syntheia’s platform targets both large enterprises and small-to-medium businesses, which often struggle with customer support inefficiencies and high employee turnover in customer-facing roles. Syntheia offers customers an experience closer to natural human interaction focusing on language processing, tonality, sentiment analysis, and conversational behavior.
The rising demand for customer-centric interactions, the need for operational efficiency, and cost reductions that companies can realize by automating and enhancing their customer support processes lead to explosive growth in AI-driven customer service solutions.
Syntheia’s AssistantNLP platform is designed to handle high volumes of customer queries in multiple languages and across industries, ensuring a scalable, reliable and flexible solution for diverse customer needs. AssistantNLP is also highly accessible, structured around a freemium revenue model that allows businesses to try the service at no cost and then upgrade based on usage and additional features.
Company Highlights
- Syntheia is a conversational AI solution delivering AI-driven, human-like customer service for enterprises and SMBs.
- The AssistantNLP Platform offers 24/7/365 multilingual support, accessible globally.
- Syntheia operates on a freemium revenue model, with scalable plans catering to varied business sizes and needs.
- The conversational AI market is expected to reach $32.62 billion by 2030, with Syntheia well-positioned to capitalize on this growth.
- Syntheia’s algorithms have achieved an 84 percent success rate in data collection and 98 percent in outreach programs, highlighting exceptional efficiency.
- Financially stable, Syntheia has $2 million in cash, no debt and trades on the Canadian Securities Exchange.
This Syntheia profile is part of a paid investor education campaign.*
Click here to connect with Syntheia (CSE:SYAI) to receive an Investor Presentation
BlinkLab Limited (ASX: BB1) – Trading Halt
Description
The securities of BlinkLab Limited (‘BB1’) will be placed in trading halt at the request of BB1, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Wednesday, 20 November 2024 or when the announcement is released to the market.
ASX Compliance
Click here for the full ASX Release
This article includes content from Blinklab Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
BlinkLab to Participate in the Landmark Monash University Autism/ADHD MAGNET Project
BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”), an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for neurological conditions, is pleased to announce their participation in the landmark MAGNET (Monash Autism & ADHD Genetics and Neurodevelopment) study conducted by Monash University’s School of Psychological Sciences.
Link: https://molecularautism.biomedcentral.com/articles/10.1186/s13229-021-00457-3
Highlights
- The MAGNET project is an ongoing large cohort study aiming to enrol 1,000 families with children diagnosed with only autism, only ADHD, or with both autism and ADHD.
- MAGNET is utilising a novel family-based trial design where the parents, affected child and siblings (either affected or unaffected) are all enrolled in the same study.
- The aim of the study is to identify novel data-driven autism and ADHD subtypes using deep phenotyping data, including the BlinkLab Dx 1 biomarkers, that may outperform current categorical diagnoses with potential future implications for better and more personalised autism and ADHD diagnosis and treatment.
The project will help to unravel the complex symptoms of autism and Attention Deficit Hyperactivity Disorder (ADHD), and why they overlap in some children. The data generated by the study will address several limitations of categorical conceptualisations of these conditions. It is an important step towards a more dimensional understanding of their psychopathology, leading to better diagnostic models and more personalised support for children diagnosed with autism and/or ADHD. Using BlinkLab Dx 1, we aim to complete comprehensive deep sensory phenotyping of subjects with only autism, only ADHD, or with both autism and ADHD from the large MAGNET cohort.
Significance of the Study
Autism and ADHD are neurodevelopmental conditions affecting 1-4% and 5-7% of the population, respectively. Autism is characterised by deficits in social communication, restricted and repetitive patterns of behaviour and interests and altered sensory processing, whereas ADHD is defined by hyperactivity, impulsivity and inattention. In autism, 30-80% of cases exhibit ADHD symptomatology. In ADHD, 20-50% of cases exhibit autism symptoms.
The introduction of the DSM-5 has allowed, for the first time, the concurrent diagnosis of autism and ADHD and the two conditions are now recognized to co-occur in up to 50% of cases. This co-occurrence can be associated with a more severe ADHD phenotype and higher treatment needs overall. DSM-5 is a comprehensive classification system published by the American Psychiatric Association (APA). It serves as the authoritative guide used by healthcare professionals to diagnose mental disorders.
Prepulse inhibition (PPI) is a key measure used in BlinkLab Dx 1 and is considered an effective proxy for sensorimotor gating - the brain's ability to filter out irrelevant information and prioritise what is relevant. Deficits in PPI have been observed in individuals with autism but not in those with ADHD, suggesting its potential as a tool to differentiate between these two conditions. Clinically, this distinction is crucial, as treatment, support, and care strategies differ significantly for individuals with only autism, only ADHD, or with both autism and ADHD. There is also little known about the extent to which any deficits in PPI extend to the undiagnosed family members of children with autism, ADHD, or with both autism and ADHD. The diagnostic process for these neurological conditions is time-consuming and expensive and they are both characterised by significant heterogeneity in presentation. Objective behavioural markers, like PPI, potentially will play an important role in the next generation of diagnostic pathways and personalised interventions.
Dr. Henk-Jan Boele, CEO BlinkLab, commented: “Participation in the MAGNET study will enable BlinkLab to assess how its digital biomarkers, including the PPI measure, correlate with other validated behavioural, neurocognitive, neuroimaging and, potentially, genetic markers. Using these deep phenotyping and machine learning techniques, we expect to uncover novel, homogeneous data-driven clusters and subtypes of these diseases with significant future implications for better and more personalised autism and ADHD diagnosis and treatment.”
Study Design
The MAGNET study will enrol approximately 1,000 families with children aged between 4 and 18 years of age. The study will incorporate the BlinkLab PPI measure to determine how prepulse inhibition measures vary within the different diagnostic categories (i.e. ADHD vs autism vs ADHD+autism). The results will show whether BlinkLab’s Dx1 platform can distinguish between these groups. BlinkLab Dx 1 platform will be assessed alongside other validated questionnaires and biomarkers used in the MAGNET project. A unique feature of the study design is that tests will be carried out with the diagnosed child and their family members. The data from both parents (wherever possible) will determine the degree to which BlinkLab can detect performance variation within families, and thus can serve as a proxy for familial risk for these conditions.
“From the very foundation of our technology, the BlinkLab mission was always to disrupt the traditional methods of diagnosis and categorisation of psychiatric and neurodevelopmental conditions. Using more objective methods will lead to more personalised treatments and interventions. Participation in this landmark study with world- leading researchers and authorities in the field of autism and ADHD, is a testament to our mission and hard work by our team,” commented CEO of BlinkLab, Dr Henk-Jan Boele.
Lead researcher Professor Mark Bellgrove of Monash University’s School of Psychological Sciences said that he is delighted to collaborate with BlinkLab on the MAGNET study. “BlinkLab’s innovative digital technologies make it easy for the children and families enrolled in the study to provide critical data. This will hopefully lead to better outcomes for future families and children affected by these two complex and challenging conditions.”
Click here for the full ASX Release
This article includes content from Blinklab Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
Latest News
Latest Press Releases
Related News
TOP STOCKS
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.